Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
In Vitro and In Vivo Models of Multiple Sclerosis.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Interferon-β1b Increases Th2 Response in Neuromyelitis Optica.
Interferon Beta and Glatiramer Acetate Therapy.
Therapeutic decision making in a new drug era in multiple sclerosis.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Depression in multiple sclerosis: A long-term longitudinal study.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Cervical dysplasia associated with the use of natalizumab.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Vitamin D levels in Hispanics with multiple sclerosis.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
Antibodies to potassium channels in multiple sclerosis.
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Jekyll and Hide: The two faces of amyloid β.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »